# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-22T22:54:26.455344

---

**Idea Fidelity**

The paper largely adheres to the manifest’s vision. It uses Census QWI data for NAICS 62141, 6211, and placebo industries to examine ban versus receiving states through a staggered post-Dobbs shock. It emphasizes the receiving-state perspective and the reallocation story advocated in the idea manifest. However, it omits a couple of original design elements: there is no use of the Callaway–Sant’Anna (2021) estimator or any staggered-te timing structure, despite the manifest’s emphasis on event-time heterogeneity, and the paper relies solely on a simultaneous two-way fixed-effects setup. Furthermore, the manifest proposed distant non-ban controls and a more explicit double-difference comparing ban, receiving, and never-treated states, whereas the paper focuses on pairwise comparisons (ban vs. others, receiving vs. others) without showing how never-treated controls behave over time. These departures should be justified.

---

**Summary**

The paper documents a “receiving-state dividend” in family planning employment after Dobbs: the ban states did not lose jobs in NAICS 62141, whereas nearby non-ban “receiving” states experienced a 25.4 log-point increase relative to controls. A triple-difference using dental offices as a placebo confirms the effect is concentrated in reproductive healthcare. The interpretation is that reproductive healthcare labor reallocated geographically rather than contracting nationally.

---

**Essential Points**

1. **Parallel-trends evidence and event study still needed.** The identifying assumption is that ban/receiving states would have followed the same trajectory as controls absent Dobbs. Table 3 or the text do not present pre-treatment trends; the robustness section does not include an event study. Without demonstrating parallel paths or estimating dynamic leads/lags, it is hard to assess whether the observed post-2022Q3 jump merely reflects pre-existing divergence (e.g., receiving states could already have been growing faster). Please plot the event-study estimates (ban and receiving relative to controls) or formally test lead coefficients before attributing the change to Dobbs. Since treatment is at a single point (2022Q3) for all treated states, visual inspection is feasible.

2. **Clarify treatment/control classification of receiving and ambiguous states.** The paper treats Colorado, Minnesota, Montana, Nebraska, etc., as “receiving states,” but some of these states either had their own restrictions (e.g., Montana) or are not necessarily documented as major abortion destinations. At the same time, states with partial bans (GA, IN, OH, SC) are swept into the control group. This classification could bias the estimates if the “controls” also experience shocks. The paper should (a) justify the receiving-state list using patient-travel or provider data, (b) test results under alternative definitions (e.g., excluding states with mixed signals, defining receiving states via distance to nearest ban), and (c) ensure that control states are truly unaffected (perhaps by dropping GA/IN/SC/OH entirely rather than just “excluding in robustness”). The paper currently lacks these clarifications.

3. **Interpretation of the null effect in ban states hinges on more than employment levels.** The conclusion that employment “relocated” relies on comparing receiving-state gains with ban-state nulls. However, QWI counts cannot distinguish between workers who repurposed toward nonabortion care, reduced hours, or relocated; the fact that total employment stays flat in ban states does not prove that abortion providers preserved their workforce. Provide additional evidence—e.g., hours worked, wages, or within-state composition—to support the reallocation story. Otherwise the symmetry assumption (ban-state null + receiving-state gain = national expansion) is not fully supported.

---

**Suggestions**

- **Show pre-trends and conduct falsification/placebo tests.** Include a figure plotting the dynamic coefficients from an event-study specification (e.g., estimating $\beta_{k}$ for $k = -8,\dots,+8$ quarters). If the coefficients are flat before 2022Q3 and spike only afterward, this will reinforce the parallel-trends assumption. Additionally, consider placebo treatments (e.g., pretending the ban occurred in 2021Q3 or using “receiving” states that do not border ban states) to demonstrate that the results are specific to the actual policy shock.

- **Explore heterogeneity within receiving states.** The receiving-state effect is pooled across nine states, but the strength of cross-border demand likely varies (e.g., Illinois vs. Colorado). Present state-level estimates or at least compare subgroups (Midwest vs. mountain states). This can reveal whether the triple-difference is driven by a few large states (e.g., Illinois) and would also speak to the mechanism—if the effect is concentrated in states with large abortion clinics, the story is consistent with new clinics opening rather than worker relocation.

- **Strengthen the triple-difference by expanding placebo industries.** The current DDD uses dental/optometry offices as the comparison industry. Consider adding physician offices or outpatient care centers as additional placebos. If the DDD remains positive only for family planning, it would bolster the claim that the effect is industry-specific. Alternatively, combining multiple placebo industries might yield a more precise counterfactual.

- **Address potential spillovers from federal/legal changes.** The Dobbs ruling led not only to bans but also to renewed federal discussions and possibly federal funding shifts that might affect healthcare employment broadly. While the paper uses dental offices as one placebo, the parallel trends assumption could still fail if receiving states had other concurrent shocks (e.g., Medicaid expansion, COVID aftershocks). Consider controlling for other contemporaneous policy changes at the state level (e.g., changes in Medicaid enrollment, population growth) or showing that outcomes in unrelated industries do not move differently in receiving states.

- **Leverage QWI’s earnings or employment stock-flow to test mechanisms.** The LEHD data contain Emp (beginning-of-quarter employment), EmpS (full-quarter employment), and earnings. A pilot analysis of earnings could reveal whether average wages rose (suggesting tighter labor markets) or fell (suggesting different composition). Similarly, comparing Emp vs. EmpS might indicate turnover. These additional margins can help distinguish between clinics expanding capacity, hiring new staff, or redeploying existing workers.

- **Clarify the derivation of the “28.2% expansion.”** The interpretation of the DDD coefficient as 28.2 percentage points faster growth assumes a log-linear relationship. Provide a back-of-the-envelope calculation or percentage change formula to make this clearer for readers less comfortable with log coefficients.

- **Discuss the external validity and policy implications with nuance.** The concluding paragraphs claim that the receiving-state expansion implies a national workforce increase. If the same workers are reallocated rather than net hiring, the story changes. Elaborate on how the findings translate into policy: What does it mean for patients’ access when receiving-state capacity rises? Are there implications for abortion access inequality given that gains occur near borders? A short paragraph situating the results within ongoing debates would strengthen the paper’s contribution.

- **Document data and code availability.** Since the paper is based on publicly available QWI data, provide a link (or appendix snippet) showing the API query structure or code used to download and process the data. This will aid replication, especially given the novel use of QWI in this context.

By addressing these points—especially the pre-trend evidence and treatment classification—the paper would substantially strengthen its identification and sharpen its contribution to the post-Dobbs literature on healthcare labor markets.
